Geron Corp (GERN):企業の財務・戦略的SWOT分析

◆英語タイトル:Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1660
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Geron Corp (GERN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Geron Corp (Geron) is a late-stage clinical biopharmaceutical company that focuses on the development and commercialization of imetelstat, a first-in-class telomerase inhibitor in hematologic myeloid malignancies. The company’s clinical studies include IMerge, a Phase 2 trial in lower risk myelodysplastic syndromes; and IMbark, a Phase 2 clinical trial in intermediate or high-risk myelofibrosis. Imetelstat received Fast Track designation from the US FDA to treat patients with transfusion-dependent anemia due to lower or intermediate risk myelodysplastic syndromes (MDS) and patients with intermediate or high-risk myelofibrosis (MF). The company utilizes core expertise in telomerase and telomere biology and its proprietary nucleic acid chemistry for the development of imetelstat. Geron is headquartered in Menlo Park, California, the US.

Geron Corp Key Recent Developments

Mar 12,2020 Geron reports fourth quarter and full year 2019 financial results and 2020 milestones
Feb 14,2020 GERON: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jan 13,2020 Geron announces 2019 accomplishments and key development priorities for 2020
Nov 06,2019 Geron reports third quarter 2019 financial results and recent events

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Geron Corp – Key Facts
Geron Corp – Key Employees
Geron Corp – Key Employee Biographies
Geron Corp – Major Products and Services
Geron Corp – History
Geron Corp – Company Statement
Geron Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Geron Corp – Business Description
Geron Corp – SWOT Analysis
SWOT Analysis – Overview
Geron Corp – Strengths
Geron Corp – Weaknesses
Geron Corp – Opportunities
Geron Corp – Threats
Geron Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Geron Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Geron Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2020: Geron reports fourth quarter and full year 2019 financial results and 2020 milestones
Feb 14, 2020: GERON: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jan 13, 2020: Geron announces 2019 accomplishments and key development priorities for 2020
Nov 06, 2019: Geron reports third quarter 2019 financial results and recent events
Aug 01, 2019: Geron reports second quarter 2019 financial results and recent events
Jun 20, 2019: Geron appoints Vice President, Human Resources
May 16, 2019: Geron Continues to Build Senior Leadership of Its Development Team
May 02, 2019: Geron Corporation reports first quarter 2019 financial results
Mar 07, 2019: Geron reports fourth quarter and full year 2018 financial results and recent events
Jan 31, 2019: Geron announces new office to be opened in New Jersey
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Geron Corp, Key Facts
Geron Corp, Key Employees
Geron Corp, Key Employee Biographies
Geron Corp, Major Products and Services
Geron Corp, History
Geron Corp, Other Locations
Geron Corp, Key Competitors
Geron Corp, Ratios based on current share price
Geron Corp, Annual Ratios
Geron Corp, Annual Ratios (Cont...1)
Geron Corp, Interim Ratios
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Geron Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Geron Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Geron Corp, Performance Chart (2015 - 2019)
Geron Corp, Ratio Charts
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Geron Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Geron Corp (GERN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ConceptoMed AS:医療機器:M&Aディール及び事業提携情報
    Summary ConceptoMed AS (ConceptoMed) is a medical device company that offers medtech systems. The company offers Luer-Jack, a medical syringe facilitating safer conditions for performing medical procedures. Its Luer-Jack provides superior usability advantages, preventing dislodging of the sharp need …
  • Oncternal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncternal Therapeutics Inc (Oncternal) is a clinical-stage oncology company that develops therapies for rare and common cancers. The company’s pipeline compounds include cirmtuzumab and TK216. Its compounds are primarily focused on exciting targets which are uniquely expressed within cancer …
  • Double Bond Pharmaceutical International AB-製薬・医療分野:企業M&A・提携分析
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that develops and commercializes treatment of autoimmune diseases, cancers, infections, and other life-threatening disorders. The company’s products include proprietary platforms SA-033, SI-053, SA-042, and SA-083. …
  • Confluent Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Confluent Medical Technologies Inc (CMT), formerly Nitinol Devices and Components Inc is a medical device company that manufactures and markets nitinol devices and balloon catheters. The company provides products such as wire, strip, sheet, tubing and bar, among others. It offers development …
  • Bryce Corporation
    Bryce Corporation - Strategy, SWOT and Corporate Finance Report Summary Bryce Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Himatsingka Seide Ltd.:戦略・SWOT・企業財務分析
    Himatsingka Seide Ltd. - Strategy, SWOT and Corporate Finance Report Summary Himatsingka Seide Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Impresario Entertainment and Hospitality Pvt., Ltd.:企業の戦略・SWOT・財務情報
    Impresario Entertainment and Hospitality Pvt., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Impresario Entertainment and Hospitality Pvt., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • Havells India Ltd (HAVELLS):企業の財務・戦略的SWOT分析
    Havells India Ltd (HAVELLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Celator Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine and daunorubicin liposomal formulation, irinotecan HCI and floxuridine and hydrophobic docetaxel …
  • The Cleveland Clinic Foundation:企業の戦略的SWOT分析
    The Cleveland Clinic Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Vermillion Inc (VRML):企業の財務・戦略的SWOT分析
    Summary Vermillion Inc (Vermillion) is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, a simple blood test …
  • Newcastle University-製薬・医療分野:企業M&A・提携分析
    Summary Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri- …
  • Otsuka Pharmaceutical Factory Inc-製薬・医療分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Factory Inc (Otsuka), a subsidiary of Otsuka Holdings Co Ltd is a provider of parenteral and enteral nutrition products. The company’s enteral nutrition products supplies nutrients such as glucose, proteins, fats, electrolytes, and vitamin. It offers over the counter pr …
  • Integrated Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company’s tools assist physicians in the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • DiaCarta Inc-医療機器分野:企業M&A・提携分析
    Summary DiaCarta Inc (DiaCarta) develops and commercializes molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation de …
  • Apex Frozen Foods Limited (APEX):企業の財務・戦略的SWOT分析
    Apex Frozen Foods Limited (APEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Merrimack Pharmaceuticals Inc (MACK):製薬・医療:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆